compare glp 1 medications GLP-1 Options | Ozempic v Mounjaro | WeightWatchers GLP-1 Medications for Weight Loss:

Can impact both the quantity and effectiveness of platelets

Changs recommendations

Special Scenarios Post-COVID generalized weakness Documentation must be separate: active infection vs post-infectious recovery Objective strength deficits functional impairment and safety concerns structured plan with measured progress Weakness in older adults Older patients require clear separation between: generalized weakness (M62.81) confirmed sarcopenia (M62.84) Neurologic causes of weakness when present Fall risk documentation strengthens medical necessity when accurate and specific

Schedule regular follow-ups to track progress, address side effects, and check results